Patents by Inventor Linda Andrus

Linda Andrus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • UNIVERSAL MULTI-VARIANT DETECTION SYSTEM
    Publication number: 20130288231
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Application
    Filed: April 4, 2013
    Publication date: October 31, 2013
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Universal Multi-Variant Detection System
    Publication number: 20120258446
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Application
    Filed: April 26, 2012
    Publication date: October 11, 2012
    Applicant: NEW YORK BLOOD CENTER, INC.
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Universal multi-variant detection system
    Patent number: 8192939
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: June 5, 2012
    Assignee: New York Blood Center, Inc.
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Universal multi-variant detection system
    Publication number: 20110053138
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Application
    Filed: January 28, 2008
    Publication date: March 3, 2011
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Universal multi-variant detection system
    Patent number: 7348164
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: March 25, 2008
    Assignee: The New York Blood Center, Inc.
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Method for extraction and identification of nucleic acids
    Publication number: 20060240409
    Abstract: The invention provides a method for extracting nucleic acids from a sample. The sample contains cells, viruses, or both cells and viruses. The method include adding a lysing solution containing a detergent to the sample to lyse the cells or viruses to form a lysate, adding alcohol to the lysate to aggregate or precipitate the nucleic acids, and purifying the nucleic acids from the lysate-alcohol mixture by filtering the mixture through a glass-fiber filter.
    Type: Application
    Filed: January 20, 2006
    Publication date: October 26, 2006
    Inventors: Alfred Prince, Wolfram Pfahler, Don-Hun Lee, Linda Andrus
  • Universal multi-variant detection system
    Publication number: 20040053284
    Abstract: The present invention provides a method to diagnostically detect the variants of a given pathogen, such as HIV, hepatitis C, hepatitis B (HBV), Parvovirus B19, etc., with the use of a single detection probe.
    Type: Application
    Filed: September 2, 2003
    Publication date: March 18, 2004
    Inventors: Linda Andrus, Carmen Nicola Nichols
  • Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
    Patent number: 5849587
    Abstract: The present invention is directed to methods which employ inhibition of the post-translational hypusine formation in the intracelluar protein eIF-5A, for the purpose of suppressing infections by viruses that parasitize eIF-5A so as to promote their own replication. Intentional inhibition of the post-translational formation of hypusine in infected host cells with compounds generically termed `hypusine inhibitors` not only selectively suppresses the production of viral proteins and of infectious viral particles, but also causes, particularly after hypusine inhibitor withdrawal, apoptosis in such virally-infected cells.
    Type: Grant
    Filed: June 9, 1995
    Date of Patent: December 15, 1998
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Hartmut M. Hanauske-Abel, Robert Walter Grady, Axel Hanauske, Linda Andrus, Paul Szabo